Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹800 Cr₹1,814 Cr₹-2,969 Cr₹-1,365 Cr₹-1,947 Cr

What is the latest Cash Flow from Financing Activities ratio of AUROBINDO PHARMA ?

The latest Cash Flow from Financing Activities ratio of AUROBINDO PHARMA is ₹800 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹800 Cr
Mar2023₹1,814 Cr
Mar2022₹-2,969 Cr
Mar2021₹-1,365 Cr
Mar2020₹-1,947 Cr

How is Cash Flow from Financing Activities of AUROBINDO PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹800 Cr
-55.89
Mar2023 ₹1,814 Cr
Positive
Mar2022 ₹-2,969 Cr
Negative
Mar2021 ₹-1,365 Cr
Negative
Mar2020 ₹-1,947 Cr -

Compare Cash Flow from Financing Activities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹68,066.9 Cr 10.9% 7.1% 4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,394.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

10.9%

7.1%

4.2%

SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses